Dr. Martens plc
DOCMF · OTC
9/30/2025 | 3/31/2025 | 3/30/2025 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $976 | $504 | – | $539 |
| - Cash | $129 | $156 | – | $95 |
| + Debt | $397 | $404 | – | $450 |
| Enterprise Value | $1,245 | $752 | – | $894 |
| Revenue | $433 | – | $463 | $325 |
| % Growth | – | – | 42.6% | – |
| Gross Profit | $236 | – | $304 | $208 |
| % Margin | 54.6% | – | 65.7% | 64% |
| EBITDA | $51 | – | $115 | -$5 |
| % Margin | 11.7% | – | 24.8% | -1.4% |
| Net Income | -$13 | – | $25 | -$21 |
| % Margin | -3.1% | – | 5.5% | -6.4% |
| EPS Diluted | -0.014 | – | 0.034 | -0.022 |
| % Growth | – | – | 253.6% | – |
| Operating Cash Flow | -$22 | – | $184 | $35 |
| Capital Expenditures | -$6 | – | -$5 | -$4 |
| Free Cash Flow | -$27 | – | $179 | $31 |